Context Capital Management’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Context Capital Management’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$3K	–	366
2023 Q1	$3K	Hold	25,000	–	–	﹤0.01%	325
2022 Q4	$5K	Hold	25,000	–	–	﹤0.01%	367
2022 Q3	$2K	Hold	25,000	–	–	﹤0.01%	562
2022 Q2	$4K	Hold	25,000	–	–	﹤0.01%	579
2022 Q1	$9K	Buy	+25,000	New	+$10.7K	﹤0.01%	653

Context Capital Management's PKBOW Position: Q2 2023 in Review

Context Capital Management sold out of Peak Bio, Inc. Warrant (PKBOW) in Q2 2023, closing a stake of 25,000 shares — an estimated $3K sold.

Context Capital Management first reported a position in PKBOW in Q1 2022 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 0 funds tracked by Wall St. Rank hold PKBOW as of Q2 2023.

Context Capital Management reported no remaining Peak Bio, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Context Capital Management sold 25,000 Peak Bio, Inc. Warrant shares in Q2 2023, an estimated $3K.
Context Capital Management first reported a position in Peak Bio, Inc. Warrant in Q1 2022 and held it in 5 quarters.
Context Capital Management's Peak Bio, Inc. Warrant position peaked at $9K in Q1 2022.
0 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q2 2023.

Based on Context Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.